{"id":4853,"date":"2020-04-16T10:13:53","date_gmt":"2020-04-16T08:13:53","guid":{"rendered":"https:\/\/digidem-bayern.de\/?p=4853"},"modified":"2020-04-16T11:36:39","modified_gmt":"2020-04-16T09:36:39","slug":"medikamente-gegen-erbliche-alzheimer-demenz-gescheitert","status":"publish","type":"post","link":"https:\/\/digidem-bayern.de\/en\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/","title":{"rendered":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert"},"content":{"rendered":"<h4 class=\"wp-block-heading\">Ein weiterer R\u00fcckschlag f\u00fcr die Alzheimer-Forschung: In einer gro\u00dfen internationalen Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Form der Alzheimer-Demenz verlangsamen sollten. Beide Arzneimittel sollten die Beta-Amyloid-Ablagerungen im Gehirn vermindern, die typisch f\u00fcr die Alzheimer-Erkrankung sind. Den geistigen Abbau haben sie jedoch nicht verhindert.<\/h4>\n\n\n\n<p>Geleitet wurde die Studie von der Washington University School of Medicine in St. Louis \/ USA. Die Wissenschaftler*innen untersuchten die Wirkung der zwei Antik\u00f6rper \u201cGantenerumab\u201d und \u201cSolanezumab\u201d bei Menschen mit der erblich bedingten Form der Alzheimer-Erkrankung, der so genannten \u201cfamili\u00e4ren Alzheimer-Erkrankung\u201d. Diese Familien weisen eine genetische Ver\u00e4nderung auf, die zu einer fr\u00fch einsetzenden Alzheimer-Demenz f\u00fchrt. Bei den Betroffenen beginnt der geistige Abbau ab dem 50ten, 40ten oder sogar 30ten Lebensjahr.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"alignright size-medium\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"200\" src=\"https:\/\/test.digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-300x200.jpg\" alt=\"Verschiedene Tabletten\" class=\"wp-image-4859\" srcset=\"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-300x200.jpg 300w, https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1030x686.jpg 1030w, https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-768x512.jpg 768w, https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x330.jpg 495w, https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg 1280w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure><\/div>\n\n\n\n<p>Die 194 Studienteilnehmer*innen wiesen noch keine oder allenfalls leichte Hinweise auf die Erkrankung auf, als sie mit der Einnahme der getesteten Medikamente begannen. Sie erhielten eines der beiden Medikamente oder ein Placebo und wurden \u00fcber einen Zeitraum von durchschnittlich f\u00fcnf Jahren beobachtet. Die beiden aktuell getesteten Medikamente sollten die Beta-Amyloid-Ablagerungen im Gehirn neutralisieren, bevor sich Anh\u00e4ufungen bilden, doch keines erzielte eine Verlangsamung des geistigen Abbaus.<\/p>\n\n\n\n<p><strong>Forschungsansatz liegt auf fr\u00fchem Beginn der Behandlung<\/strong><\/p>\n\n\n\n<p>Auch wenn die Vererbung f\u00fcr die Familien dramatisch ist, bildet sie f\u00fcr die Wissenschaft einen wichtigen Ansatzpunkt: Betroffene k\u00f6nnen identifiziert werden, bevor der kognitive R\u00fcckgang einsetzt. So lassen sich neue Therapien testen, die in der Fr\u00fchphase einer (auch sp\u00e4ten) Alzheimer-Erkrankung wirksam sein k\u00f6nnten. Wichtig erscheint diese Behandlung auch vor dem Hintergrund vergangener Kritik: Fehlschl\u00e4ge bei der Suche nach Alzheimer-Medikamenten wurden danach auf einen zu sp\u00e4ten Beginn einer Behandlung zur\u00fcckgef\u00fchrt. Wenn es einmal zu einer Anh\u00e4ufung der Beta-Amyloid- und Tau-Ablagerungen gekommen sei, lasse sich der Krankheitsverlauf nicht mehr aufhalten, so die Annahme. Daher liegt ein Forschungsansatz &#8211; auch der aktuellen Studie &#8211; auf einem m\u00f6glichst fr\u00fchen Beginn der Therapie.&nbsp;<\/p>\n\n\n\n<p>An der Studie waren 42 Forschungszentren in 14 L\u00e4ndern beteiligt, es handelte sich um eine Zusammenarbeit zwischen Universit\u00e4ten, Pharma-Unternehmen, staatlichen Forschungseinrichtungen, Patientenverb\u00e4nden und privaten Spendern.<\/p>\n\n\n\n<p>Hier finden Sie weitere Informationen:<\/p>\n\n\n\n<p><a href=\"https:\/\/medicine.wustl.edu\/news\/alzheimers-diantu-trial-initial-results\/\" target=\"_blank\" rel=\"noreferrer noopener\">Pressemitteilung der Washington University School of Medicine<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.alz.org\/news\/2020\/dian-tu-phase-3-clinical-trials-topline-results\" target=\"_blank\" rel=\"noreferrer noopener\">Pressemitteilung der Alzheimer\u2019s Asscoiation:<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01760005\" target=\"_blank\" rel=\"noreferrer noopener\">Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer&amp;apos;s Disease Caused by a Genetic Mutation. (DIAN-TU)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Ein weiterer R\u00fcckschlag f\u00fcr die Alzheimer-Forschung: In einer gro\u00dfen internationalen Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Form der Alzheimer-Demenz verlangsamen sollten. Beide Arzneimittel sollten die Beta-Amyloid-Ablagerungen im Gehirn vermindern, die typisch f\u00fcr die Alzheimer-Erkrankung sind. Den geistigen Abbau haben sie jedoch nicht verhindert. &hellip;<\/p>","protected":false},"author":11,"featured_media":4859,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"qubely_global_settings":"true","qubely_interactions":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[5],"tags":[12,14,17,55,102,101],"class_list":["post-4853","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-wissenschaft-forschung","tag-demenz-2","tag-digidem","tag-digidem-bayern","tag-digitales-demenzregister-bayern","tag-erbliche-alzheimer-erkrankung","tag-familiaerer-alzheimer"],"qubely_featured_image_url":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1200x750.jpg",1200,750,true],"portraits":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-540x320.jpg",540,320,true],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-768x512.jpg",768,512,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1030x686.jpg",1030,686,true],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1200x750.jpg",1200,750,true],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x330.jpg",495,330,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x350.jpg",495,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",394,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1024x853.jpg",1024,853,true]},"qubely_author":{"display_name":"Michael Zeiler","author_link":"https:\/\/digidem-bayern.de\/en\/author\/michael-zeiler\/"},"qubely_comment":0,"qubely_category":"<a href=\"https:\/\/digidem-bayern.de\/en\/category\/wissenschaft-forschung\/\" rel=\"category tag\">Wissenschaft &amp; Forschung<\/a>","qubely_excerpt":"Ein weiterer R\u00fcckschlag f\u00fcr die Alzheimer-Forschung: In einer gro\u00dfen internationalen Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Form der Alzheimer-Demenz verlangsamen sollten. Beide Arzneimittel sollten die Beta-Amyloid-Ablagerungen im Gehirn vermindern, die typisch f\u00fcr die Alzheimer-Erkrankung sind. Den geistigen Abbau haben sie jedoch nicht verhindert. &hellip;","featured_image_urls_v2":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-768x512.jpg",768,512,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1030x686.jpg",1030,686,true],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1200x750.jpg",1200,750,true],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x330.jpg",495,330,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x350.jpg",495,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",394,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1024x853.jpg",1024,853,true]},"post_excerpt_stackable_v2":"<p>Ein weiterer R\u00fcckschlag f\u00fcr die Alzheimer-Forschung: In einer gro\u00dfen internationalen Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Form der Alzheimer-Demenz verlangsamen sollten. Beide Arzneimittel sollten die Beta-Amyloid-Ablagerungen im Gehirn vermindern, die typisch f\u00fcr die Alzheimer-Erkrankung sind. Den geistigen Abbau haben sie jedoch nicht verhindert. Geleitet wurde die Studie von der Washington University School of Medicine in St. Louis \/ USA. Die Wissenschaftler*innen untersuchten die Wirkung der zwei Antik\u00f6rper \u201cGantenerumab\u201d und \u201cSolanezumab\u201d bei Menschen mit der erblich bedingten Form der Alzheimer-Erkrankung, der so genannten \u201cfamili\u00e4ren Alzheimer-Erkrankung\u201d. Diese Familien weisen eine genetische Ver\u00e4nderung auf, die zu&hellip;<\/p>\n","category_list_v2":"<a href=\"https:\/\/digidem-bayern.de\/en\/category\/wissenschaft-forschung\/\" rel=\"category tag\">Wissenschaft &amp; Forschung<\/a>","author_info_v2":{"name":"Michael Zeiler","url":"https:\/\/digidem-bayern.de\/en\/author\/michael-zeiler\/"},"comments_num_v2":"0 comments","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern<\/title>\n<meta name=\"description\" content=\"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/digidem-bayern.de\/en\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern\" \/>\n<meta property=\"og:description\" content=\"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/digidem-bayern.de\/en\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/\" \/>\n<meta property=\"og:site_name\" content=\"digiDEM Bayern\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/digiDEMBayern\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-16T08:13:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-16T09:36:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Michael Zeiler\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Zeiler\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/\"},\"author\":{\"name\":\"Michael Zeiler\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/92754ad381f49b3c358d1d8d2c4f90b8\"},\"headline\":\"Medikamente gegen erbliche Alzheimer-Demenz gescheitert\",\"datePublished\":\"2020-04-16T08:13:53+00:00\",\"dateModified\":\"2020-04-16T09:36:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/\"},\"wordCount\":415,\"publisher\":{\"@id\":\"\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/headache-1540220_1280.jpg\",\"keywords\":[\"Demenz\",\"digidem\",\"digidem Bayern\",\"Digitales Demenzregister Bayern\",\"erbliche Alzheimer-Erkrankung\",\"famili\u00e4rer Alzheimer\"],\"articleSection\":[\"Wissenschaft &amp; Forschung\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/\",\"name\":\"Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern\",\"isPartOf\":{\"@id\":\"\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/headache-1540220_1280.jpg\",\"datePublished\":\"2020-04-16T08:13:53+00:00\",\"dateModified\":\"2020-04-16T09:36:39+00:00\",\"description\":\"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#primaryimage\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/headache-1540220_1280.jpg\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/headache-1540220_1280.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Verschiedene Tabletten\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/digidem-bayern.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medikamente gegen erbliche Alzheimer-Demenz gescheitert\"}]},{\"@type\":\"WebSite\",\"@id\":\"\\\/#website\",\"url\":\"\\\/\",\"name\":\"digiDEM Bayern\",\"description\":\"Das digitale Demenzregister Bayern erforscht und verbessert die Angebotsstuktur f\u00fcr Menschen mit Demenz und deren Angeh\u00f6rige\",\"publisher\":{\"@id\":\"\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"\\\/#organization\",\"name\":\"digiDEM Bayern\",\"url\":\"\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"width\":612,\"height\":357,\"caption\":\"digiDEM Bayern\"},\"image\":{\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/digiDEMBayern\\\/\",\"https:\\\/\\\/x.com\\\/digidem_bayern\",\"https:\\\/\\\/www.instagram.com\\\/digidem.bayern\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/digidem-bayern\\\/\"]},{\"@type\":\"Person\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/92754ad381f49b3c358d1d8d2c4f90b8\",\"name\":\"Michael Zeiler\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/en\\\/author\\\/michael-zeiler\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern","description":"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/digidem-bayern.de\/en\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/","og_locale":"en_US","og_type":"article","og_title":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern","og_description":"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.","og_url":"https:\/\/digidem-bayern.de\/en\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/","og_site_name":"digiDEM Bayern","article_publisher":"https:\/\/www.facebook.com\/digiDEMBayern\/","article_published_time":"2020-04-16T08:13:53+00:00","article_modified_time":"2020-04-16T09:36:39+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg","type":"image\/jpeg"}],"author":"Michael Zeiler","twitter_misc":{"Written by":"Michael Zeiler","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#article","isPartOf":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/"},"author":{"name":"Michael Zeiler","@id":"\/#\/schema\/person\/92754ad381f49b3c358d1d8d2c4f90b8"},"headline":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert","datePublished":"2020-04-16T08:13:53+00:00","dateModified":"2020-04-16T09:36:39+00:00","mainEntityOfPage":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/"},"wordCount":415,"publisher":{"@id":"\/#organization"},"image":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg","keywords":["Demenz","digidem","digidem Bayern","Digitales Demenzregister Bayern","erbliche Alzheimer-Erkrankung","famili\u00e4rer Alzheimer"],"articleSection":["Wissenschaft &amp; Forschung"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/","url":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/","name":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert - digiDEM Bayern","isPartOf":{"@id":"\/#website"},"primaryImageOfPage":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#primaryimage"},"image":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg","datePublished":"2020-04-16T08:13:53+00:00","dateModified":"2020-04-16T09:36:39+00:00","description":"In einer Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Alzheimer-Form verlangsamen sollten. Beide scheiterten.","breadcrumb":{"@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#primaryimage","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg","width":1280,"height":853,"caption":"Verschiedene Tabletten"},{"@type":"BreadcrumbList","@id":"https:\/\/digidem-bayern.de\/medikamente-gegen-erbliche-alzheimer-demenz-gescheitert\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/digidem-bayern.de\/"},{"@type":"ListItem","position":2,"name":"Medikamente gegen erbliche Alzheimer-Demenz gescheitert"}]},{"@type":"WebSite","@id":"\/#website","url":"\/","name":"digiDEM Bavaria","description":"The digital dementia register in Bavaria researches and improves the structure of services for people with dementia and their relatives","publisher":{"@id":"\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"\/#organization","name":"digiDEM Bavaria","url":"\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/#\/schema\/logo\/image\/","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","width":612,"height":357,"caption":"digiDEM Bayern"},"image":{"@id":"\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/digiDEMBayern\/","https:\/\/x.com\/digidem_bayern","https:\/\/www.instagram.com\/digidem.bayern","https:\/\/www.linkedin.com\/company\/digidem-bayern\/"]},{"@type":"Person","@id":"\/#\/schema\/person\/92754ad381f49b3c358d1d8d2c4f90b8","name":"Michael Zeiler","url":"https:\/\/digidem-bayern.de\/en\/author\/michael-zeiler\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-768x512.jpg",768,512,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1030x686.jpg",1030,686,true],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1200x750.jpg",1200,750,true],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x330.jpg",495,330,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-495x350.jpg",495,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",394,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",36,24,false],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280.jpg",1280,853,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-460x350.jpg",460,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2020\/04\/headache-1540220_1280-1024x853.jpg",1024,853,true]},"uagb_author_info":{"display_name":"Michael Zeiler","author_link":"https:\/\/digidem-bayern.de\/en\/author\/michael-zeiler\/"},"uagb_comment_info":0,"uagb_excerpt":"Ein weiterer R\u00fcckschlag f\u00fcr die Alzheimer-Forschung: In einer gro\u00dfen internationalen Studie wurden zwei Arzneimittel getestet, die den geistigen Abbau bei der erblich bedingten Form der Alzheimer-Demenz verlangsamen sollten. Beide Arzneimittel sollten die Beta-Amyloid-Ablagerungen im Gehirn vermindern, die typisch f\u00fcr die Alzheimer-Erkrankung sind. Den geistigen Abbau haben sie jedoch nicht verhindert. &hellip;","_links":{"self":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/4853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/comments?post=4853"}],"version-history":[{"count":0,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/4853\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media\/4859"}],"wp:attachment":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media?parent=4853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/categories?post=4853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/tags?post=4853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}